Mice inoculated with B16.F10 melanoma cells expressing the CD8+ T cell epitope GP33 and treated with rLCMV-GP33 eight days post-inoculation survived longer than mice treated with adenovirus 5 GP33 (rAd-GP33) or vaccinia virus GP33 (VACC-GP33) vaccines. Here, CD8A is linked to melanoma.